Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANALYSIS: Healthcare IT lifts September’s VC takings

This article was originally published in Clinica

Executive Summary

September brought a new low in the number of medtech venture financing deals, with only 16 transactions of $1m or over recorded. This is the smallest monthly deal volume this year to date, and is a significant 20% drop from August, which only had 20 transactions (www.clinica.co.uk, 10 September 2013). However, dollar-wise, September beat August by raking in over $209m, not including the one transaction that did not disclose the sum raised. This was down to the absence of big-buck deals in August, where the total VC dollars raised slipped just past $179m, while September had a whopping $70m Series D transaction to hike up the total deal value that month (see Fig 1). Excluding this transaction, the total deal value for September would have been well below that of August at $139m, as there was even a significant decrease in the number of small, below-$10m financings.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100925

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel